Johansen ME, Argyropoulos C. The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use Sodium Glucose Cotransporter 2 inhibitors is now. Clin Cardiol 2020 Nov 9. doi: 10.1002/clc.23508.
PMID: 33165977